# FDA Inspection 592443 - Theravance Biopharma US, Inc. - June 25, 2009

Source: https://www.globalkeysolutions.net/records/fda_inspections/theravance-biopharma-us-inc/debf5dd9-cca6-45af-8815-8fe8f7bece07
Source feed: FDA_Inspections

> FDA Inspection 592443 for Theravance Biopharma US, Inc. on June 25, 2009. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 592443
- Company Name: Theravance Biopharma US, Inc.
- Inspection Date: 2009-06-25
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1059781 - 2018-07-12](https://www.globalkeysolutions.net/records/fda_inspections/theravance-biopharma-us-inc/220952df-b224-4a14-91ef-90d036dee5bf)
- [FDA Inspection 934536 - 2015-06-26](https://www.globalkeysolutions.net/records/fda_inspections/theravance-biopharma-us-inc/929c9454-9ffb-41c1-b60c-9cbab064f376)
- [FDA Inspection 795363 - 2012-08-27](https://www.globalkeysolutions.net/records/fda_inspections/theravance-biopharma-us-inc/976da035-18e1-4a96-aa36-6b3cec84b924)

Company: https://www.globalkeysolutions.net/companies/theravance-biopharma-us-inc/9c134845-f418-4948-a8c8-65be6f595653

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
